Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer “cell therapy” clinics
BACKGROUND: The retinal pigment epithelium (RPE) is implicated in the pathophysiology of many retinal degenerative diseases. This cell layer is also an ideal target for cell-based therapies. Several early phase clinical trials evaluating cell therapy approaches for diseases involving the RPE, such a...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504041/ https://www.ncbi.nlm.nih.gov/pubmed/34635174 http://dx.doi.org/10.1186/s13287-021-02546-9 |